Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
tiotropium bromide
|
| gptkbp:approvalYear |
2004
|
| gptkbp:ATCCode |
R03BB04
|
| gptkbp:availableOn |
gptkb:HandiHaler
gptkb:Respimat |
| gptkbp:brand |
tiotropium
|
| gptkbp:contraindication |
allergy to atropine derivatives
hypersensitivity to tiotropium |
| gptkbp:drugClass |
long-acting muscarinic antagonist
|
| gptkbp:eliminationRoute |
urine
feces |
| gptkbp:form |
inhalation powder
inhalation solution |
| gptkbp:halfLife |
5-6 days
|
| https://www.w3.org/2000/01/rdf-schema#label |
Spiriva
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Boehringer_Ingelheim
|
| gptkbp:mechanismOfAction |
muscarinic receptor antagonist
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:sideEffect |
constipation
glaucoma dry mouth urinary retention |
| gptkbp:usedFor |
asthma
chronic obstructive pulmonary disease |
| gptkbp:bfsParent |
gptkb:Boehringer_Ingelheim
|
| gptkbp:bfsLayer |
6
|